Literature DB >> 4031155

Complex aphthosis: a forme fruste of Behçet's syndrome?

J L Jorizzo, R S Taylor, F C Schmalstieg, A R Solomon, J C Daniels, H E Rudloff, T Cavallo.   

Abstract

The evaluation of the rare patient who presents with oral and genital aphthae or almost constant, multiple (greater than 3) oral aphthae, but no systemic signs or symptoms (i.e., complex aphthosis), is difficult because no laboratory test is available to exclude Behçet's syndrome. Six patients with complex aphthosis were evaluated. In addition, patients with simple aphthosis, those with seronegative arthritis, and normal controls were assessed for circulating immune complexes (CIC) by in vitro and in vivo assays and for neutrophil migration by subagarose methods, since these tests have given significant results in patients with Behçet's syndrome. Patient 1, with complex aphthosis, had Raji cell evidence for CIC (51.2 mg aggregated human gamma globulin Eq/ml), C1q, and C3 in dermal blood vessels 4 hours post intradermal histamine injection and had a Sweet's syndrome-like vasculitis 24 hours post histamine injection. In addition, her serum enhanced the migration of patient neutrophils (3.6 +/- 0.6 to 4.6 +/- 0.5; N = 6, p less than or equal to 0.01). All other test and control patients had negative or normal CIC and neutrophil migration determinations. Sixteen-month clinical follow-up has confirmed that Patient 1, but not Patients 2 to 6, has developed overt manifestations of Behçet's syndrome.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4031155     DOI: 10.1016/s0190-9622(85)70147-8

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  7 in total

Review 1.  Clinical Immunology Review Series: an approach to the patient with recurrent orogenital ulceration, including Behçet's syndrome.

Authors:  M T Keogan
Journal:  Clin Exp Immunol       Date:  2008-12-11       Impact factor: 4.330

2.  Clinical study to know the efficacy of Amlexanox 5% with other topical Antiseptic, Analgesic and Anesthetic agents in treating minor RAS.

Authors:  D D Darshan; C N Vijay Kumar; A D Manoj Kumar; N S Manikantan; Dhanya Balakrishnan; M P Uthkal
Journal:  J Int Oral Health       Date:  2014-02-26

Review 3.  Urban legends: recurrent aphthous stomatitis.

Authors:  L Baccaglini; R V Lalla; A J Bruce; J C Sartori-Valinotti; M C Latortue; M Carrozzo; R S Rogers
Journal:  Oral Dis       Date:  2011-08-04       Impact factor: 3.511

Review 4.  [Autoinflammatory diseases as cause of wound healing defects].

Authors:  R Löhrer; R Eming; N Wolfrum; T Krieg; S A Eming
Journal:  Hautarzt       Date:  2011-07       Impact factor: 0.751

Review 5.  Mucocutaneous lesions of Behcet's disease.

Authors:  Erkan Alpsoy; Christos Constantin Zouboulis; George Edward Ehrlich
Journal:  Yonsei Med J       Date:  2007-08-31       Impact factor: 2.759

Review 6.  Behçet Disease: An Update for Dermatologists.

Authors:  Erkan Alpsoy; Burcin Cansu Bozca; Asli Bilgic
Journal:  Am J Clin Dermatol       Date:  2021-06-01       Impact factor: 7.403

7.  Amlexanox for the treatment of recurrent aphthous ulcers.

Authors:  Juliette Bell
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.